Clinical Leader Webinar

  1. CAR T Cell Therapy And Other Technologies Emerging In Oncology Research
    4/18/2019

    Some unique CAR T cell therapies have already been approved by the US Food and Drug Administration (FDA) and are the first steps toward further groundbreaking science. In this webinar, Emile Youssef, Premier Research’s Executive Medical Director, reviews the operational and clinical pathways that are helping to bring these technologies to patients.

  2. Webinar: The Benefits Of EDC-eSource Integration
    4/15/2019

    Get insight into why the best way to reduce costs and timelines through eSource direct data capture is with a solution that comes integrated with your central EDC. You’ll get key info for understanding eSource and how best to approach vendor selection.

  3. Overcoming Clinical Supply Chain Challenges In Investigator Initiated Studies
    4/12/2019

    Investigator Initiated Studies (IIS) offer pharmaceutical sponsor companies the benefit of increasing product knowledge and expanding the medical use of their drug. However, managing these studies presents unique clinical supply chain challenges and can become a very complex process. In this webinar, Almac’s clinical supply experts address these challenges and provide insight into how to best manage investigator initiated clinical studies.

  4. Optimizing Your Direct-To-Patient Clinical Trial Logistics Webinar
    3/27/2019

    Patient enrollment and retention remain a critical variable in clinical trial studies. Increasingly, sponsors are looking to the DTP trial model for certain patient populations, such as the elderly and critically ill. Watch this on-demand webinar and learn how to optimize your distribution chain for direct-to-patient clinical trials.

  5. eConsent: The Good, The Bad, And The Regulatory
    3/18/2019

    The clinical trial informed consent process is in dire need of optimization. High patient attrition rates indicate that we’re not doing enough to ensure patients truly understand the nature of their participation in clinical trials. We can do better. This webinar explains how organizations are using eConsent to enhance patient engagement, discusses regulatory considerations around eConsent, and more.

  6. eCOA Translations And Cultural Adaptation: Best Practices And Efficiencies
    3/15/2019

    While translation and cultural adaptation are time-intensive and require domain expertise, there are emerging best practices that not only save time, but also eliminate unnecessary work and reduce risk of error and timeline delays. his webinar will discuss the process of translation and cultural adaptation to support eCOA implementation on a global scale.

  7. Demystifying IRT Terminology Webinar
    3/15/2019

    “Configurable” and “customizable” are two commonly-used descriptors for interactive response technology systems that support clinical trials. Interpretations of these terms can vary widely. This webinar discusses definitions and system functionality in the context of configurable and customizable and includes systems development life cycle (SDLC) methodologies, the impact on timelines and cost and common applications in interactive response technology system designs.

  8. Protecting The Integrity Of Your Temperature Data In A Digital World
    2/26/2019

    Watch Almac’s on-demand webinar to gain an understanding of data integrity regulations and key considerations when utilizing a computerized system to manage temperature data during clinical trials.  This webinar will demonstrate how a secure, validated system is key in ensuring effective collection and management of accurate temperature data from the entire clinical supply chain.  

  9. Ready for eSource? Preparing For The Future Of Clinical Research
    2/19/2019

    Enhancing your data entry and monitoring and, as a result, strengthen your competitive edge. With eSource poised to become the next standard in clinical trial technology, the time is now to prepare for a new era in our industry.

  10. Right-To-Try Or Right-to-Ask? Understanding Right-To-Try And FDA’s Expanded Access
    1/29/2019

    Right-to-Try has been in the news a lot recently, but what does it actually mean for product sponsors? This webinar explores both Right-to-Try legislation and existing Expanded Access Programs, including understanding sponsor responsibilities under these programs and when products may be eligible for these programs, evaluating options such as treatment protocols, treatment INDs, and emergency use, and discussing development risks associated with participation in these programs.